结节性T滤泡辅助细胞淋巴瘤的蛋白质组学分析揭示独特生物学特征并改善IPI之外的预后分层
该研究对63例初诊结节性T滤泡辅助细胞淋巴瘤(nTFHL)患者进行质谱蛋白质组学分析,通过无监督聚类识别出两种具有不同通路富集和显著总生存差异(p=0.02)的蛋白质组特征。研究进一步筛选出10蛋白标志物 panel 并在31例独立验证队列中验证其预后价值,结合IPI构建的IPI-P评分可细化风险分层(p<0.001)。
要点
- nTFHL存在两种蛋白质组特征:基质型和翻译型,后者总生存更差。
- 10蛋白标志物 panel 可准确预测蛋白质组特征并在验证队列中重现生存差异。
- 翻译型特征为独立于IPI的不良预后因素(HR=1.92,p=0.01),IPI-P评分改善风险分层。
核心结论
- nTFHL存在两种 distinct 蛋白质组程序,翻译型特征与更差OS独立相关,IPI-P评分可细化预后分层。
研究设计与样本
- 发现队列纳入63例初诊nTFHL患者,采用质谱分析经典和替代蛋白质组,无监督k-means聚类。
- 独立验证队列纳入31例nTFHL患者,验证10蛋白标志物 panel 及预后差异。
主要发现
- 发现队列中识别出nTFHL-基质型和nTFHL-翻译型两种特征,总生存差异显著(p=0.02)。
- 翻译型特征富集蛋白生物合成和细胞增殖通路,基质型特征表现为复杂微环境。
- 验证队列中10蛋白 panel 准确预测蛋白质组特征并重现OS差异。
- 多因素Cox回归显示翻译型特征与更差OS相关(HR=1.92,p=0.01),独立于IPI。
- IPI-P评分识别出三组总生存显著不同的患者(p<0.001)。
关键数值与推荐
- 总生存差异显著性阈值p=0.02(发现队列两种特征比较)。
- 翻译型特征多因素HR=1.92,p=0.01。
- IPI-P评分三组OS差异p<0.001。
临床怎么用
- 基于10蛋白 panel 的蛋白质组分型可辅助nTFHL预后评估,IPI-P评分可在IPI基础上细化风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nodal T-follicular helper cell lymphoma (nTFHL), most commonly of angioimmunoblastic type, exhibits heterogeneous clinical outcomes that are not fully explained by current clinical and biological variables. While genetic alterations have been extensively investigated, its proteomic landscape remains largely unexplored. Here, in a discovery cohort, the classical and alternative proteome of 63 nTFHL patients at diagnosis was profiled by mass spectrometry and analyzed using unsupervised k-means clustering. Two nTFHL signatures with distinct pathway enrichment and significantly different overall survival (p = 0.02) were identified: the nTFHL-stromal profile, characterized by a complex microenvironment, and the nTFHL-translational profile, enriched in protein biosynthesis and cell proliferation pathways. Profile discrimination was confirmed across multiple supervised learning algorithms, enabling selection of a 10-protein biomarker panel validated by immunofluorescence. In an independent validation cohort including 31 nTFHL patients, the 10-protein panel accurately predicted the proteomic profiles, reproducing the observed difference in overall survival. In multivariable Cox regression, the nTFHL-translational profile remained associated with poorer OS (HR = 1.92, p = 0.01), independently of the International Prognostic Index (IPI). Integration of the proteomic profile with the IPI generated the IPI-P score, which refined risk stratification and identified three groups with significantly different overall survival (p < 0.001). Overall, these findings reveal distinct proteomic programs underlying nTFHL heterogeneity and provide a clinically applicable framework for proteome-based prognostic stratification.
引用
- Beauvais D, Zirem Y, Cardon T, et al. Proteomic Profiling of Nodal T-Follicular Helper Cell Lymphoma Reveals Distinct Biological Signatures and Improves Prognostic Stratification Beyond the IPI. Am J Hematol. 2026. PMID: 42820458. doi:10.1002/ajh.70502
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。